Source: International Congress 2016 – Molecular immunology of the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kshitij Agarwal (New Delhi, India), Kshitij Agarwal, Roger Bruggemann, Anuradha Chowdhary, J.F. Meis, S.N. Gaur. Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis. Eur Respir J 2016; 48: Suppl. 60, 4956

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Asthma Year: 2013 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Place of azoles in the treatment of allergic bronchopulmonary candidiasis Source: Eur Respir J 2006; 28: Suppl. 50, 52s Year: 2006 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Sublingual immunotherapy among patients, suffering from allergic rhinitis Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 432s Year: 2001 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations Source: Eur Respir Rev 2014; 23: 149-152 Year: 2014 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007